Ayurveda management in Mild Neuro Cognitive Disorder

Efficacy Of Saraswata Ghrita In Mild Neuro Cognitive Disorder -A Randomized Controlled Clinical Trial - nil

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038804

Enrollment

Registered

2021-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G300- Alzheimers disease with early onset

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age above 50 years of either sex Diagnosed as Mild Neurocognitive Disorder as per DSM V criteria Possible sub types of Alzheimers disease Frontotemporal lobar degeneration Lewy body disease Vascular disease Monteral cognitive assessment scale MOCA less than 22

Exclusion criteria

Exclusion criteria: Other Neuro cognitive disorders due to Parkinson’s disease trauma medical conditions etc Substantial neuropsychiatric or behavioral symptoms. Patients with severe or uncontrolled somatic disorders. Patients with clinically relevant depression [ Cornell Scale for Depression in Dementia (CSDD) >10 Patient on any other medications like psychotropic, neurotropic etc since 4 weeks Patient with substance abuse like alcohol, tobacco etc

Design outcomes

Primary

Measure	Time frame
Saraswata ghrita if proved more efficacious would help in the better management of Mild neuro cognitive disorder.Timepoint: at baseline, 30th,60th and 90th day.	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr B R Tubaki

KAHERS Shri BMK Ayurveda Mahavidyalaya

ayurbasavaraj@gmail.com9418540175

Outcome results